|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dy GW, Gore JL, Forouzanfar MH, Naghavi M
and Fitzmaurice C: Global burden of urologic cancers, 1990–2013.
Eur Urol. 71:437–446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
La Vecchia C, Bosetti C, Lucchini F,
Bertuccio P, Negri E, Boyle P and Levi F: Cancer mortality in
Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol.
21:1323–1360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang X, Du L, Wang L, Li J, Liu Y, Zheng
G, Qu A, Zhang X, Pan H, Yang Y and Wang C: Serum microRNA
expression signatures identified from genome-wide microRNA
profiling serve as novel noninvasive biomarkers for diagnosis and
recurrence of bladder cancer. Int J Cancer. 136:854–862. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M; European
Association of Urology (EAU), : EAU guidelines on
non-muscle-invasive urothelial carcinoma of the bladder, the 2011
update. Eur Urol. 59:997–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu XR: Urothelial tumorigenesis: A tale of
divergent pathways. Nat Rev Cancer. 5:713–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Black PC, Brown GA and Dinney CP:
Molecular markers of urothelial cancer and their use in the
monitoring of superficial urothelial cancer. J Clin Oncol.
24:5528–5535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng L, Zhang S, MacLennan GT, Williamson
SR, Lopez-Beltran A and Montironi R: Bladder cancer: Translating
molecular genetic insights into clinical practice. Hum Pathol.
42:455–481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiu HW, Lin SW, Lin LC, Hsu YH, Lin YF,
Ho SY, Wu YH and Wang YJ: Synergistic antitumor effects of
radiation and proteasome inhibitor treatment in pancreatic cancer
through the induction of autophagy and the downregulation of TRAF6.
Cancer Lett. 365:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng L, Wang C, Spencer E, Yang L, Braun
A, You J, Slaughter C, Pickart C and Chen ZJ: Activation of the
IkappaB kinase complex by TRAF6 requires a dimeric
ubiquitin-conjugating enzyme complex and a unique polyubiquitin
chain. Cell. 103:351–361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen H, Li M, Campbell RA, Burkhardt K,
Zhu D, Li SG, Lee HJ, Wang C, Zeng Z, Gordon MS, et al:
Interference with nuclear factor kappa B and c-Jun NH2-terminal
kinase signaling by TRAF6C small interfering RNA inhibits myeloma
cell proliferation and enhances apoptosis. Oncogene. 25:6520–6527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang KZ, Galson DL and Auron PE: TRAF6 is
autoinhibited by an intramolecular interaction which is
counteracted by trans-ubiquitination. J Cell Biochem. 110:763–771.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamothe B, Besse A, Campos AD, Webster WK,
Wu H and Darnay BG: Site-specific Lys-63-linked tumor necrosis
factor receptor-associated factor 6 auto-ubiquitination is a
critical determinant of I kappa B kinase activation. J Biol Chem.
282:4102–4112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi YB and Harhaj EW: HTLV-1 tax
stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination
to promote cell survival and transformation. PLoS Pathog.
10:e10044582014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaudhry SI, Hooper S, Nye E, Williamson
P, Harrington K and Sahai E: Autocrine IL-1β-TRAF6 signalling
promotes squamous cell carcinoma invasion through paracrine TNFα
signalling to carcinoma-associated fibroblasts. Oncogene.
32:747–758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi
C, Zhou X, Bian X, Ping Y, et al: miR-146b-5p functions as a tumor
suppressor by targeting TRAF6 and predicts the prognosis of human
gliomas. Oncotarget. 6:29129–29142. 2015.PubMed/NCBI
|
|
17
|
Rong Y, Wang D, Wu W, Jin D, Kuang T, Ni
X, Zhang L and Lou W: TRAF6 is over-expressed in pancreatic cancer
and promotes the tumorigenicity of pancreatic cancer cells. Med
Oncol. 31:2602014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu H, Zhang T, Ye J, Li H, Huang J, Li X,
Wu B, Huang X and Hou J: TNF receptor-associated factor 6 in
advanced non-small cell lung cancer: Clinical and prognostic
implications. J Cancer Res Clin Oncol. 138:1853–1863. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3:170222017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Xu Y, Zhang Q, Yang H, Shi W, Liu
Z, Li K, Gong Z, Ning S, Li S and Chen Y: Prognostic significance
of TBL1XR1 in predicting liver metastasis for early stage
colorectal cancer. Surg Oncol. 26:13–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal
M, Ning SL, Yang H, Suo N and Chen YX: Fibroblast growth factor
receptor 4 promotes progression and correlates to poor prognosis in
cholangiocarcinoma. Biochem Biophys Res Commun. 446:54–60. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Yang X, Li Z, Li S, Guo S, Ismail S,
Liu H, Huang Z, Zhang Z, Chen Y and Sun Q: Sprouty2 correlates with
favorable prognosis of gastric adenocarcinoma via suppressing
FGFR2-induced ERK phosphorylation and cancer progression.
Oncotarget. 8:4888–4900. 2017.PubMed/NCBI
|
|
23
|
Hemdan T, Lindén M, Lind SB, Namuduri AV,
Sjöstedt E, de Ståhl TD, Asplund A, Malmström PU and Segersten U:
The prognostic value and therapeutic target role of stathmin-1 in
urinary bladder cancer. Br J Cancer. 111:1180–1187. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang XQ, Xu YF, Guo S, Liu Y, Ning SL, Lu
XF, Yang H and Chen YX: Clinical significance of nerve growth
factor and tropomyosin-receptor-kinase signaling pathway in
intrahepatic cholangiocarcinoma. World J Gastroenterol.
20:4076–4084. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Xu Y, Zhang Q, Li K, Wang D, Li S,
Ning S, Yang H, Shi W, Liu Z and Chen Y: Correlations between
TBL1XR1 and recurrence of colorectal cancer. Sci Rep. 7:442752017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Solomon JP and Hansel DE: Prognostic
factors in urothelial carcinoma of the bladder: Histologic and
molecular correlates. Adv Anat Pathol. 22:102–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gogalic S, Sauer U, Doppler S and
Preininger C: Bladder cancer biomarker array to detect aberrant
levels of proteins in urine. Analyst. 140:724–735. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan EC, Pasikanti KK, Hong Y, Ho PC,
Mahendran R, Nee Mani L Raman, Chiong E and Esuvaranathan K:
Metabonomic profiling of bladder cancer. J Proteome Res.
14:587–602. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitra AP, Bartsch CC and Cote RJ:
Strategies for molecular expression profiling in bladder cancer.
Cancer Metastasis Rev. 28:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang M, Chu H, Li P, Yuan L, Fu G, Ma L,
Shi D, Zhong D, Tong N, Qin C, et al: Genetic variants in miRNAs
predict bladder cancer risk and recurrence. Cancer Res.
72:6173–6182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shaid S, Brandts CH, Serve H and Dikic I:
Ubiquitination and selective autophagy. Cell Death Differ.
20:21–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pickart CM: Ubiquitin enters the new
millennium. Mol Cell. 8:499–504. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang WL, Wang J, Chan CH, Lee SW, Campos
AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG and Lin HK: The
E3 ligase TRAF6 regulates Akt ubiquitination and activation.
Science. 325:1134–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin Y, Qiu Y, Xu C, Liu Q, Peng B,
Kaufmann GF, Chen X, Lan B, Wei C, Lu D, et al: Functional role of
asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion
and metastasis. J Natl Cancer Inst. 106:dju0122014. View Article : Google Scholar : PubMed/NCBI
|
